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This reaction was quenched by addition of DTT (final concentration of 2 mM). Then the sample was diluted 4x and digested by incubation with LysC (1:75 enzyme to protein) and
Trypsin (1:50 enzyme to protein) for 10 h at 37 °C, after which formic acid (1%) was added to quench the digestion. Finally, peptides were desalted by C 18 Seppak prior to both IMAC enrichment as well as LC-MS analysis.
o Phosphatase treatment of crosslinked cytosolic human cell lysate peptides.
Desalted peptides were dissolved at a concentration of 3 μg/μL in 1x CutSmart buffer (NEB, 50 mM potassium acetate, 20 mM tris-acetate, 10 mM magnesium acetate, 100 μg/mL BSA, pH 7.9). A volume of 2.4 μL of Alkaline phosphatase, calf intestinal (CIP, NEB, 10000 units/mL) was added and the mixture was incubated at 37 °C overnight with shaking. Additionally, peptides were desalted using C 18 Seppak.
E.coli spike-in experiment.
For the "sensitivity experiment", BSA peptides were mixed with E.coli-peptides in w/w ratios of 16:100, 8 :100, 4:100, 2:100, 1:100 and 0.5:100. For the "recovery experiment", BSA peptides were mixed with E.coli peptides in w/w ratios of 10:0, 10:10, 10:100 and 10:1000. The mixed peptides were desalted using C 18 Seppak prior to IMAC enrichment and LC-MS analysis.
Supplementary Note 2 -Enrichment
Automated Fe(III)-IMAC-Based Workflow. Crosslinked peptides were enriched with Fe(III)-NTA-5 μL in an automated fashion using the AssayMAP Bravo Platform (Agilent Technologies; Santa Clara, Ca). 2 Fe(III)-NTA cartridges were primed with 250 μL of 0.1% TFA in ACN and equilibrated with 250 μL of loading buffer (80% ACN/0.1% TFA). Samples were dissolved in 200 μL of loading buffer and loaded onto the cartridge.
The columns were washed with 250 μL of loading buffer, and the crosslinked peptides were eluted with 25 μL of 10% ammonia directly into 25 μL of 10% formic acid. Samples were dried down and stored in 4 °C until subjected to LC-MS/MS. For LC-MS/MS analysis the samples were resuspended in 10% formic acid.
Supplementary Note 3 -Mass Spectrometry Acquisition
LC-MS/MS. The data were acquired using an UHPLC 1290 system (Agilent Technologies; Santa Clara, Ca) coupled on-line to an Orbitrap Fusion mass spectrometer (Thermo Scientific; San Jose, Ca). 3 Trypsin was specified as the cleavage enzyme with a minimal peptide length of six and up to two miss cleavages were allowed. Filtering at 1% false discovery rate (FDR) at the peptide level was applied through the Percolator node. For crosslinked peptides, a database search was performed against a FASTA containing the proteins under investigation supplemented with a common contaminants list of 200 proteins using XlinkX nodes for crosslink analysis. For the complex human lysate we used a filtered human FASTA file, as described in the main text. PhoX (C 8 H 3 O 5 P) was set as the crosslink modification. Cysteine carbamidomethylation was set as a fixed modification and methionine oxidation and protein N-term acetylation was set as dynamic modifications. Trypsin was specified as enzyme and up to two miss cleavages were allowed. Furthermore, identifications were only accepted with a minimal score of 40 and a minimal delta score of 4. Otherwise, standard settings were applied. Filtering at 1% false discovery rate (FDR) at peptide level was applied through the XlinkX Validator node with setting simple. The standard proteome discoverer node Minora Feature Detector was used for precursor ion quantification for all identifications. Shortly, all false discovery rate corrections were calculated with the classical target decoy strategy as described by Elias et al. 5 The false discovery rate correction in both cases is estimated in a data driven fashion. The classical strategy uses protein databases containing both targets (real peptide sequences) and decoys (typically full proteins are reversed and then in-silico digested into peptides leading to naturally possible but still incorrect peptide sequences). After scoring the fragmentation spectra against the peptide sequences (both target and decoy), the spectra are sorted by their score. The algorithms then simply count the number of target and decoy matches in the list for each score and determines the score cutoff required to retain matches at 1% decoys. More advanced schemes using machine learning have been developed which work in a similar fashion but operate on many more factors (exemplified in Percolator used for the linear peptide identifications). with the XlinkX nodes. The settings for the individual nodes are described above.
In the consensus step, the results from the processing workflow are subjected to a final filtering step and organized in the output tables. We utilize a standard setup for this step, apart from integrating the nodes Crosslink Stoichiometry. To the best of our knowledge, so far no one reported the reaction efficiency of crosslinking molecules. To calculate a reasonable value for this efficiency -or as we term it crosslink stoichiometry -we make use of the precursor abundances as produced by the Minora to make a calculation analogous to that performed for PTM stoichiometry determinations. 6 For a crosslinked peptide pair, the precursor abundances for all peptides containing the lysines involved in the crosslink are collected. The formula below provides a reasonable approximation for the crosslink stoichiometry.
We have calculated the stoichiometry for an older dataset, which provides the precursor abundance values for the detected crosslinks peptide pairs. 7 For the used crosslinking reagent DSSO 8 we find a crosslink stoichiometry of approximately 5 %. For the crosslinking reagents in this study, we calculate the same crosslink stoichiometry of approximately 5 %, leading us to conclude that generally speaking a crosslink reaction efficiency of 5 % is to be expected when using NHS esters to covalently link connect lysine residues in close proximity.
To determine what this reaction efficiency specifically means in terms of contribution of crosslinked peptide pairs to the total ion flux into the mass spectrometer (i.e. the sum of all measured peptide abundances) we in-silico digested BSA and calculated the ratio in abundance between the unmodified + mono-linked peptides and the crosslinked peptides. From this calculation we estimate that approximately 0.14% of the ions entering the mass spectrometer consist of crosslinked peptides. arm utilized in PhoX results in very small variation in the lengths it is able to span (0.5 Å compared to ~6 Å that DSSO is able to span) and is roughly half the length as that of other linkers like DSS and DSSO, potentially providing advantages for protein structure studies. At the same time, the rigidity of PhoX will not interfere with the crosslinking reaction due to the fact that highly flexible lysine side chains are targeted. The planar aromatic ring structure present on PhoX has furthermore the advantage to occupy only a very small chemical space compared to highly flexible linkers.
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Supplementary Figure 3: cLogP values for PhoX and a range of widely used crosslinking reagents.
To get insight into what constitutes an optimal chemical space for a crosslinking reagent we calculated the surface area in pyMol (function 'get_area') for most of the currently used crosslinking reagents as a proxy for the chemical space ( Supplementary Fig. 3 ). The calculated values for non-enrichable crosslinkers occupy a limited band of areas between 1100 and 1500 Å 2 . Established enrichable crosslinking reagents utilizing Biotin as enrichment handle double the chemical space they occupy. PhoX on the other hand occupies a chemical space that fits with the non-enrichable crosslinking reagents and can be expected to have the same performance in terms of preventing sterical hindrance.
A further consideration in the design of PhoX is its cLogP value, which is a measure for its hydrophilicity and hydrophobicity in its neutral state, which we estimated by calculation with ChemDraw Professional 17.0. Solubility of the crosslinking reagent is of concern, as a too hydrophobic or hydrophilic reagent potentially will not effectively react with the amino residues and provide poor results.
Supplementary Figure 4: cLogP values for PhoX and a range of widely used crosslinking reagents.
To get insight into what constitutes an optimal cLogP value for a crosslinking reagent we calculated the cLogP values for most of the currently used crosslinking reagents ( Supplementary Fig. 4 ). The estimated values for these reagents also occupy a limited band of cLogP values between -3 and 0.5 on the full range of possible cLogP values (marked in grey). The design of PhoX incorporates an aromatic ring not only for its rigid character, as described above, but it also alleviates the hydrophilic character of the phosphonic acid group bringing the final design within the optimal cLogP range. We do note that pH is a factor for ionization state and at neutral pH our compound is slightly more hydrophilic than its neutral form. We expect that under neutral pH mostly the singly negatively charged form exists, for which we calculate a cLogP value of -2.21 (still within the optimal range).
We further did not expect nor observe any influence of this negative charge on the crosslinking reaction or the protein structure (see results for complex lysate in Supplementary Note 12). Commonly used crosslinking reagents are as well charged molecules (see Supplementary Fig. 5 ). DSSO for example incorporates a sulfoxide, which is a zwitter-ionic functional group with a highly polarized double bond resulting in a negative charge on the oxygen and a positive charge on the sulfur atoms. The commonly used crosslinking reagent BS3 is a negatively charged molecule carrying two negative charges on the sulfates of the reactive groups. Even though these are removed upon crosslinking, their presence in close proximity to the protein surface (e.g. as mono-link) could be suspected to result in structural rearrangement. We are however not aware of reports to this effect. Another example of charged crosslinkers would be zero-distance crosslinking, which with the activation step strips all negative charges of D and E; which is a dramatic alteration to the protein and potentially might induce massive repercussions for structural rearrangement. Furthermore, the activation reagents (EDC and DMTMM) also carry positive charges. However, as far as we are aware no reports have surfaced that this indeed is a problem. 
Supplementary Note 6 -PhoX stability under fragmentation conditions
PhoX was added to a mix of synthetic peptides (10 µL, 5 mM in 1xPBS, sequences: Ac-ASQKRPSQRHG-OH and Ac-IEAEKGR-OH) at a final concentration of 2 mM. The crosslinking reaction was incubated for one hour at room temperature and then stopped by addition of 5 µL Tris·HCl (100 mM, pH 8). After desalting with C 18 Seppak, the peptide mixture was directly injected into an Orbitrap Fusion mass spectrometer (Thermo Scientific; San Jose, Ca). 3 Ions with masses corresponding to crosslinked peptides or monolinks were manually isolated in the Orbitrap analyzer and subjected to increasing CID or HCD energy. PhoX (m/z = 783.08, z=3) at a HCD energy of 25% NCE. At this energy, an additional peak with a lower mass is observed that corresponds to a water loss on the crosslink. (b) Abundance at maximum of the first spectrum for the crosslinked peptides ("precursor", m/z = 783.08, z=3, in red) and the specific water loss products ("water loss", in blue) at increasing fragmentation energy. Apart from the water-loss and normal peptide fragmentation (not shown) no additional fragmentation involving the crosslinking reagent or phosphonate handle is observed.
Utilizing a phosphonic acid stabilizes the bond, inhibiting the abundant neutral loss of phosphate observed in related phosphopeptides, resulting in clean fragmentation spectra amenable to automated data analysis ( Supplementary Fig. 6a and b ). 
Supplementary Note 7 -PhoX crosslinking optimization on SDS-page
Supplementary Note 8 -PhoX performance on BSA
Initial performance test on Bovine Serum Albumin (BSA) reveals that IMAC enrichment of PhoX crosslinked peptides yields 97% enrichment specificity and 300x enrichment efficiency ( Supplementary Fig. 9 ). Fig. 10 ). For the intact protein mixture we observe a 22x enrichment efficiency of crosslinked peptides, and a 95 % enrichment specificity. 
Supplementary Note 9 -PhoX performance on Intact Protein Mix
Supplementary Note 10 -Application to RAP/LRP1
LRP1 is involved in many critical cellular processes where it acts as a signaling molecule or scavenger of a wide array of structurally and functionally different ligands, like apolipoproteins, blood coagulation factors, and many others. 9 The cellular uptake of ligands bound to LRP1 is regulated through receptormediated endocytosis, after which the receptor-ligand complex is delivered to the endosomal compartments where the ligand dissociates and is finally degraded in lysosomal compartments while the receptor is recycled to the cell surface. 10, 11 LRP1 is a 504.6 kDa protein organized in four LDL-receptor like repeats (Cluster I-IV) and eight β-propeller domains linked together by twelve EGF-like domains. Intracellular binding to up to three RAP proteins to the LDL-receptor like repeats assists in correct folding of LRP1 and importantly protects against unintended ligand binding. 12 Prolow-density lipoprotein receptor-related protein 1 (LRP1) cluster II was expressed in baby hamster kidney (BHK) cells and purified as described. 13 This cluster II fragment contains an amino acid tag which is utilized for detection of cluster II with horseradish peroxidase-labelled monoclonal antibody CLB-CAg69. 14 
Full-length rat GST-tagged Ras-related protein (GST-RAP)
, which as previously demonstrated to has strong affinity to human LRP1 due to 95% sequence homology, was expressed and purified as described. 13 Modeling of human LRP1 Cluster II. The structure for LRP1 Cluster II is currently not available; however, a crystal structure for cluster I is available (PDB: 1n7d). 16 We used this structure as a template to model the final Cluster II structure with I-TASSER. 17 As final structure, we selected the best scoring model from the prediction ( Supplementary Fig. 11a ). This model exhibits an RMSD to our template PDB: 1n7d of 2.13 Å, showing good agreement, which is slightly reduced due to the highly flexible nature of LRP1.
Modeling of rattus norvegicus RAP.
A structure for the rat version of RAP is currently not available;
however, for the human version of RAP an excellent NMR structure is available (PDB: 2p03). 18 We used this structure as a template to model the final RAT structure with I-TASSER. To bring the sequence in-line with the Uniprot sequences used to analyze the mass spectrometry data, we included the signal peptide during the modeling. This was removed for investigation of the crosslink distances and the docking procedure described in the next paragraph. As final structure, we selected the best scoring model from the prediction ( Supplementary Fig. 11b ). This model has an RMSD to our template PDB: 2p03 of 0.91 Å, demonstrating excellent agreement. As final inspection, we verified whether lysines K293 and K307 remain exposed on the D3 domain. These lysines are involved in the interaction with LRP1 and need to be accessible, which is the case in our model ( Supplementary Fig. 11c ).
Multi-body docking with HADDOCK. The large linker between the D1 and D2 domains and the smaller, but still very flexible linker between the D2 and D3 domains has led to the hypothesis that RAP has the ability to undergo a large structural rearrangement upon binding. 19 Such a feature is evolutionary desirable, as RAP interacts with many different proteins making the ability to rearrange the structure key in ensuring high affinity to all interactors. From the detected crosslinks it was evident that indeed structural rearrangement occurs, as all intra-domain links are well within the distance constraint set for PhoX, but the inter-domain links are not ( Fig. 4c and e main text) . When guiding the I-TASSER modeling process with the detected inter-domain crosslinks we indeed observe a large degree of movement of the D2 domain relative to the D3 domain ( Supplementary Fig. 12a ). Furthermore, to ensure that the lysines K293 and K307 on RAP are in close proximity to the acidic pockets on LRP1 we additionally added a distance constraint between these lysines and the acidic pocket (highlighted in blue). We also ran the docking with the lysine / acidic pocket connection reversed, as it is unclear which lysine and acidic pocket pair actually interact. For the contact between the domains D1 and D2 we did define any distance constraints as the linker is large enough to capture almost any conformation of the two domains.
We selected best scoring model with the closest contact between the lysines and the acidic for each orientation of the lysine to acidic pocket. For the model with orientation K293 to D326 we observe close contact between K293 to D326 and K307 to D283 with Cα-Cα distances of 16 and 13 Å (HADDOCK Score:
-314.6 +/-5.9, RMSD: 19.9 +/-1.1; Supplementary Fig. 12b ). The connection between the domains D2 and D3 requires structural rearrangement of the terminal coil on D3, which in terms of flexibility is feasible.
For the model with orientation K293 to D283 we observe a much less favorable contact between K293 to D326 and K307 to D283 with Cα-Cα distances of 16 and 26 Å and the interacting coil and lysines rotated away from LRP1 (HADDOCK Score: -314.2 +/-16.7, RMSD: 3.8 +/-2.4; Supplementary Fig. 12c ). The connection between the domains D2 and D3 on the other hand is more favorable in this model. As the model with orientation K293 to D326 is in closer contact with the acidic pockets and locates the D2 domain only with n-terminal loop on LRP1, which is expected because the c-terminal domain contained no crosslinks, we adopted this as the most likely model and used this for further analyses. Even though it is assign(resid 307 and segid A and name CA) (resid 68 and segid D and name CA) 10 5 10 assign(resid 216 and segid C and name CA) (resid 307 and segid A and name CA) 10 5 10 assign(resid 166 and segid C and name CA) (resid 311 and segid A and name CA) 10 5 10 assign(resid 311 and segid A and name CA) (resid 160 and segid C and name CA) 10 5 10 assign(resid 307 and segid A and name CA) (resid 174 and segid C and name CA) 10 5 10 assign(resid 307 and segid A and name CA) (resid 243 and segid C and name CA) 10 5 10 assign(resid 307 and segid A and name CA) (resid 166 and segid C and name CA) 10 5 10 assign(resid 307 and segid A and name CA) (resid 160 and segid C and name CA) 10 5 10 assign(resid 311 and segid A and name CA) (resid 162 and segid C and name CA) identifications. The same trend can be seen in the abundance of the identified crosslinks and phosphopeptides (see Supplementary Fig. 13 ). 
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5-(Bis(benzyloxy)phosphoryl)isophthalic acid (3b; is shown as 3 in the paper)
